Skip to main content
Caplight Logo









AlayaCare

AlayaCare

Private
MontrealHealthcare & Life Scienceshttps://alayacare.com

Last Round

Debt

Feb 19, 2026

Total Funding Raised

$267.68M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AlayaCare operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Debt round in February 2026.

AlayaCare is a healthcare technology company that provides an end-to-end, cloud-based software platform for home and community care agencies.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

AlayaCare Comparables

Compare AlayaCare with similar companies based on industry and business-model similarity.

AlayaCare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axxess Technology Solutions
84%
HHAeXchange
83%
AxisCare
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

AlayaCare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtFeb 19, 2026
Series DJun 23, 2021
DebtAug 27, 2020
Series C ExtensionJan 6, 2020
Series CJul 2, 2019
Series B
Aug 7, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Uros Stekovic

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

AlayaCare Investors

Notable investors and investment history

AlayaCare investors
InvestorRounds
Maple LeafSeed
Maple Leaf AngelsSeed, Grant, Series A
Investissement QuébecSeries C, Series C Extension, Series D
Inovia CapitalSeries D, Series B, Series C, Series C Extension
Investissement QuébecSeries C, Series C Extension, Series D
CIBC Innovation BankingDebt
Desjardins CapitalSeries C Extension
Book a demo to see all 16 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 30, 2026

    New 'Supplier Portal' project is in development.

  • May 11, 2026

    Nightingale, a home care and NDIS software platform, has been acquired.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • partners_withNov 3, 2026

    AlayaCare and Interim HealthCare Inc. work closely through a Home Health Product Advisory Committee to help shape the future of home health in the United States.

  • launchesNov 3, 2026

    At the Better Outcomes keynote in New York on Nov 3rd '26, AlayaCare announces its Medicare home health solution, which brings home health onto its AI-native platform and lets agencies manage multiple care lines in one system.

  • integrates_withOct 18, 2026

    AlayaCare offers a partner integration with Caredove Inc.'s eReferral platform, enabling staff to screen leads and send qualified client details into case management; the integration requires a premium subscription starting at $200 per month.

  • attends_eventSep 16, 2026

    AlayaCare attends Better Outcomes Canada 2026 in Canada on Sep 14th-15th '26 and unveils new AlayaFlow agentic AI capabilities for frontline caregivers.

  • integrates_withAug 11, 2026

    On Aug 11th '26, AlayaCare and St. Joseph's Health System Corporation announce a planned integration connecting hospital and home care systems in Ontario for bi-directional clinical data exchange, with go-live anticipated by early 2027.

Book a demo to see all news

For institutional investors. Book with your work email.

AlayaCare Filings

Explore SEC and related filing metadata, where available.

AlayaCare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about AlayaCare's valuation, stock price, and market status.

Is AlayaCare a public or private company?

AlayaCare is a private company.

What is the current stock price of AlayaCare?

AlayaCare is a private company, so its shares have no public market price. Caplight tracks AlayaCare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is AlayaCare worth (valuation)?

Valuation information for AlayaCare is not publicly available.

Can I buy AlayaCare stock?

AlayaCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was AlayaCare's last funding round?

AlayaCare's most recent funding round was Debt on February 19, 2026.

Who are the main investors in AlayaCare?

Key investors in AlayaCare include Inovia Capital, CIBC Innovation Banking, Generation Investment Management, Caisse de dépôt et placement du Québec, Klass Capital.

Will AlayaCare IPO soon?

No public IPO plans have been announced for AlayaCare.

How can I track AlayaCare secondary market activity?

Caplight tracks bids, offers, and trades in AlayaCare's shares on secondary markets.

Firmographic Details

HeadquartersMontreal
Employee Range501
Year Founded2014
Last FundingFeb 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?